Wielenberg CF, Fostitsch JC, Volz C, Marks R, et al. FDG-PET/CT is a powerful tool to predict and evaluate response to chimeric antigen receptor (CAR) T-cell therapy in Non-Hodgkin-Lymphoma (NHL). Nuklearmedizin 2024 Apr 9. doi: 10.1055/a-2283-8417.
PMID: 38593856